Buy or sell ArsenalBio stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

ArsenalBio Stock

ArsenalBio is a programmable cell therapy company.

About ArsenalBio Stock

ArsenalBio is building a programmable cell therapy company to create highly effective and accessible immune cell therapies to impact outcomes for a much broader number of patients, initially those with cancer. Founded in 2019, ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop in immune cell therapies. With its programmable and computationally driven approach, ArsenalBio aspires to evolve critical metrics of success for immune cell therapies, including enhanced and broader efficacy, increased patient safety, reduced provider costs, and expanded market access.

Funding History

October 2019$85.0M

Management

Chief Technology Officer

Tarjei Mikkelsen

Chief Scientific Officer

Jane Grogan

CEO, President & Director

Ken Drazan

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from ArsenalBio or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo